IDH1 and neoplasm: The two classes could be distinguished with respect to several clinicopathological features and gene expression profiles, including tumor grade, radiotherapy, IDH mutation status, X1p19q co-deletion status, age, and survival outcome (Figure 3B; p < 0.05).